Reaction equation
[CH2:1]([N:4]1[CH2:9][CH2:8][O:7][CH2:6][CH2:5]1)[CH:2]=[CH2:3].Br[C:11]1[CH:12]=[C:13]([NH:21][C:22](=[O:24])[CH3:23])[CH:14]=[C:15]([C:17]([F:20])([F:19])[F:18])[CH:16]=1.N1(CCCC2C=C(NC(=O)C)C=C(C(F)(F)F)C=2)CCCCC1>>[N:4]1([CH2:1][CH2:2][CH2:3][C:11]2[CH:12]=[C:13]([NH:21][C:22](=[O:24])[CH3:23])[CH:14]=[C:15]([C:17]([F:18])([F:19])[F:20])[CH:16]=2)[CH2:9][CH2:8][O:7][CH2:6][CH2:5]1Participants
4
Procedure
N-[3-(3-Morpholin-4-yl-propyl)-5-trifluoromethyl-phenyl]-acetamide was prepared from allyl morpholine and N-(3-bromo-5-trifluoromethyl-phenyl)-acetamide similar to that described in the preparation of N-[3-(3-piperidin-1-yl-propyl)-5-trifluoromethyl-phenyl]-acetamide.
Sources & evidence
- ORD record
- ord-479692c976d74e3ca11206c5f54106de
- Source dataset
- uspto-grants-2012_08
- Patent number
- US08247556B2
Linked notes
Loading…